中文版
|
English
Home
Products
About us
Support
Custom Synthesis
Contact
A
B
C
D
E
F
G
H
I
L
O
P
R
S
T
V
W
X
Y
Pharmacology
Transporters
Nuclear Receptors
Ion Channels
7-TM Receptors
Aurora Kinase Inhibitors
Activators
Cell Cycle/Checkpoint
CETP inhibitor
PI3K/Akt/mTOR
Angiogenesis/Tyrosine Kinase
HDAC
Cytochrome P450
Apoptosis
Proteases/HSP90/HSP70
Wnt/Hedgehog/Notch
Other Pharmacology
Research Area
Immunology
Infection
Cardiovascular Disease
Antivirals
Cancer
Product Type
Peptides
Natural Compounds
Product Information
Home
>>>
Product Class
>>>
Pharmacology
>>> 
Angiogenesis/Tyrosine Kinase
>>> 
EGFR(HER)/VEGFR-PDGFR
C14316 Vandetanib(AZD6474)
Synonyms:AZD6474,Zactima
CAS No.:443913-73-3
Molecular Formula:C22H24BrFN4O2
Molecular Weight:475.35
Solubility:DMSO
Appearance:White powder
Purity:>99%
Pakage:500mg,1g,2g,5g
Storage:at -20℃
Vandetanib(AZD6474) Introduction:
Chemical Name:
4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline
Biological Activity:
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. In vitro, two cell lines (OZ and HuCCT1), both of which harboured KRAS mutation, were refractory to vandetanib, one cell line (TGBC24TKB) was somewhat resistant, and another cell line (TKKK) was sensitive. The most sensitive cell line (TKKK) had EGFR amplification. Vandetanib (25 mg /kg/ day) significantly prolonged the time to metastasis in an intravenous model of TKKK metastasis.
Related Article:
Related Products:
C14041 AP24534(Ponatinib)
C14316 Vandetanib(AZD6474)
C14347 WZ4002
C13420 XL184(Cabozantinib)
C13404 Brivanib alaninate(BMS-582664)
Copyright© 2003-2019
Chembest Research Laboratories Limited
All rights reserved. 沪ICP备11035973号
Tel :+86-21-20908456
Fax:+86-21-58180499-808
Address:No.3377 Kangxin Road, Pudong New District,Shanghai,China
PostCode:201318